Clinical trial NCT06227078: Effects of Kinesiotaping and Physiotherapy in Grade 2 Osteoarthritis Following Degenerative Meniscal Tears
Official title: Clinical and Functional Effects of Kinesiotaping and Physiotherapy in Grade 2 Osteoarthritis Following Degenerative Meniscal Tears in Football Players - A Randomized Control Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Knee Osteoarthritis
Meniscus Tear
Lead sponsor: Prince Sattam Bin Abdulaziz University
Sponsor class: OTHER
First posted: 2024-01-26
Enrollment: 56
Sex: ALL
Minimum age (years): 18
Maximum age (years): 35
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Degenerative meniscal tears are a common cause of osteoarthritis commonly diagnosed in football players and are considered a major risk factor for the development of knee osteoarthritis. This study aimed to investigate the Clinical and functional effects of kinesiotaping and physiotherapy in grade 2 osteoarthritis following degenerative meniscal tears in football players.

Detailed description: Degenerative meniscal tears represent a prevalent issue among football players and are frequently associated with an increased risk of developing knee osteoarthritis. This study seeks to explore the clinical and functional impacts of employing kinesiotaping and physiotherapy as interventions in grade 2 osteoarthritis resulting from degenerative meniscal tears in football players.

Kinesiotaping is a therapeutic technique involving the application of specialized elastic tapes to targeted areas, aiming to support injured muscles and joints, enhance circulation, and alleviate pain. Physiotherapy, on the other hand, employs a range of exercises and modalities to promote healing and improve joint function. Both modalities are commonly used in sports medicine to manage musculoskeletal injuries.

The investigation focuses on football players diagnosed with grade 2 osteoarthritis secondary to degenerative meniscal tears. Grade 2 osteoarthritis signifies moderate cartilage loss and potential joint instability. The participants will be divided into two groups: one receiving kinesiotaping in combination with physiotherapy and the other undergoing conventional physiotherapy alone.

Clinical assessments will include pain levels, joint swelling, and range of motion. Functional outcomes such as strength, agility, and proprioception will be measured through standardized tests. The study's duration and follow-up periods will allow for a comprehensive evaluation of both short-term and long-term effects.

The hypothesis underlying this research posits that the combined approach of kinesiotaping and physiotherapy will yield superior outcomes compared to traditional physiotherapy alone. Potential benefits may include reduced pain, improved joint stability, enhanced functional capacity, and a decreased risk of further degeneration.

By shedding light on the efficacy of these interventions, this study aspires to contribute valuable insights to the field of sports medicine, aiding in the development of evidence-based strategies for managing degenerative meniscal tears and mitigating the risk of osteoarthritis in football players. The findings could inform clinical practice and potentially influence rehabilitation protocols for athletes facing similar challenges.

Eligibility criteria: Inclusion Criteria:

Diagnosis of Knee Osteoarthritis:

Individuals with a confirmed diagnosis of knee osteoarthritis based on clinical and/or radiological assessments.

Mild to Moderate Knee OA:

Kinesiotaping may be more appropriate for individuals with mild to moderate knee OA rather than severe cases.

Presence of Pain and Discomfort:

Individuals experiencing pain, discomfort, or limitations in function related to knee osteoarthritis.

Functional Limitations:

Those with functional limitations in activities of daily living or reduced mobility due to knee OA.

No Contraindications:

Individuals without contraindications to kinesiotaping, such as skin allergies, infections, or open wounds in the application area.

Willingness to Participate:

Individuals who are willing to participate in and adhere to the kinesiotaping intervention.

Not Responsive to Other Conservative Treatments:

Those who have tried and not responded adequately to other conservative treatments for knee OA, such as exercise, physical therapy, or oral medications.

Absence of Serious Comorbidities:

Individuals without serious comorbidities or medical conditions that may contraindicate the use of kinesiotaping.

Individual Preferences:

Consideration of individual preferences and acceptance of kinesiotaping as part of the treatment plan.

Exclusion Criteria:

* 1. Skin Conditions:

  * Active skin infections, allergies, or open wounds in the area where kinesiotape is to be applied.
  * Skin conditions that may be aggravated or worsened by the adhesive in the tape. 2. Vascular Disorders:
  * Conditions that affect blood circulation, such as peripheral vascular disease, deep vein thrombosis, or other vascular disorders, which may be worsened by the application of kinesiotape.

    3. Peripheral Neuropathy:
  * Individuals with peripheral neuropathy or other nerve disorders, as kinesiotaping may affect sensation, and there is a risk of injury or discomfort.

    4. Cancer or Tumors:
  * Active cancer or tumors in the region where kinesiotape is to be applied, as kinesiotaping could interfere with cancer treatment or exacerbate symptoms.

    5. Joint Instability:
  * Individuals with severe joint instability, as kinesiotape may not provide sufficient support for highly unstable joints.

    6. Allergies to Tape Components:
  * Known allergies to the materials or adhesive used in kinesiotape. 7. Circulatory Disorders:
  * Severe circulatory disorders, which may be exacerbated by the pressure or tension applied by kinesiotape.

Primary outcomes:
measure: Pain intensity - Visual analog scale
timeFrame: Baseline
measure: Pain intensity - Visual analog scale
timeFrame: 8 weeks
measure: Pain intensity - Visual analog scale
timeFrame: 6 months
Secondary outcomes:
measure: Functional disability - WOMAC
timeFrame: Baseline
measure: Functional disability - WOMAC
timeFrame: 8 weeks
measure: Functional disability - WOMAC
timeFrame: 6 months
measure: Sports performance - Timed up and go test
timeFrame: Baseline
measure: Sports performance - Timed up and go test
timeFrame: 8 weeks
measure: Sports performance - Timed up and go test
timeFrame: 6 months
measure: Sports performance - 40 Metre zig zag test
timeFrame: Baseline
measure: Sports performance - 40 Metre zig zag test
timeFrame: 8 weeks
measure: Sports performance - 40 Metre zig zag test
timeFrame: 6 months
measure: Quality of life - SF-12
timeFrame: Baseline
measure: Quality of life - SF-12
timeFrame: 8 weeks
measure: Quality of life - SF-12
timeFrame: 6 months
Other outcomes:
Locations:
city: Al Kharj
country: Saudi Arabia
facility: Saud Alrawilli
state: Riyad
Study officials:
References: